The Science and Technology
PGxHealth™ has extensive experience and capabilities in the delivery of genomic-based tests and the development of efficacy and safety biomarkers for appropriate drug utilization. Through its own resources, work conducted with some of the world’s most prestigious genomics thought leaders and institutions, and use of innovative technologies, PGxHealth is concentrating on disease states and therapeutic classes that have significant impact on the cost of care and from which patients can benefit most. PGxHealth is focused on genetic tests that utilize unique biomarkers to determine which individuals will experience optimal benefit from specific therapies and, in some cases, to identify genetic diseases. We have branded our genetic tests based on these proprietary genetic markers Therapeutic Diagnostics™. |
Improved Care, Better Outcomes
PGxHealth’s ultimate objective is to provide genetic tests that assist healthcare providers in determining the most efficacious and safe therapies for their patients as well as, in some instances, propensity for developing a given disease. By employing genetic testing in the practice of care, we expect to:
- Positively impact costs related to the use of therapeutics and the delivery of medical care
- Increase efficacy of treatment
- Improve patient safety
- Improve patient care and quality of life
PGxHealth has a seasoned management team with a deep understanding of medical care delivery, the financial dynamics in healthcare as well as the value propositions for healthcare’s key constituents, and the link between the science of genomics and its clinical utility. The Company is focused on maximizing value for these constituents through the introduction of Therapeutic Diagnostics into the care delivery equation.
|
